Qualitative Disorder (1) - 1

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 27

Qualitative

Platelet Disorders
Objectives
• Describe the defects in Bernard Soulier
Syndrome and Glanzmann Thrombasthenia.
• Understand the laboratory findings for the
qualitative platelet disorders.
• Learn about the storage pool disorders.
• Compare the von Willebrand Disease to
Bernard Soulier Syndrome.
Platelet Function

Figure 45-07.   Scanning electron micrograph of resting (A) and activated (B) platelets.
Platelet Action
Qualitative Defects
• May be either:
1. Congenital
 Platelet surface
membrane defects
 Platelet release or
secretion defects
 Platelet coagulant activity
defects
 Defects associated with
abnormal platelet-
coagulant protein
interactions
2. Acquired

Graphic accessed URL http://www.accessmedicine.com/loadBinary.aspx?name=licha&filename=licha_IV.A.018.jpg, 2008.


Qualitative Platelet Disorders Summary:
Clinical Presentation & Lab Findings

 Bleeding
Similar to what is seen with
thrombocytopenic disorders

 Lab Screen Results


 Similar to what is seen with thrombocytopenic
disorders EXCEPT the platelet count is normal
 Bleeding Time – prolonged
 Platelet count– normal

 Special platelet function tests discriminate


the nature of the defect
Congenital Qualitative Defects
CLASSIFICATIONS:

 Platelet surface membrane defects


Platelet release or secretion defects
Platelet coagulant activity defects
Defects associated with abnormal platelet-
coagulant protein interactions
PLATELET SURFACE
MEMBRANE DEFECTS
Bernard Soulier Syndrome
(Giant Platelet Syndrome)
 Adhesion defective
 Inherited in autosomal recessive
pattern
 Consanguinity often noted in
affected families
 Missing or defective GP Ib/IX
receptor
 Usually undetectable vWF
 Thus cannot bind what? Giant platelets in Bernard-Soulier
syndrome (peripheral blood, ×1000).
 Clinical findings (Modified from Carr JH, Rodak BF:
Clinical Hematology Atlas, 2nd ed.
 Usually present with abnormal Philadelphia: Saunders, 2004.)
bleeding in childhood
 Severity variable, but may require
transfusion and hormonal control
of menses in females

Graphic accessed http://evolvels.elsevier.com/section/default.asp?id=1138_ccalvo7_0001, 2008.


Bernard Soulier Syndrome
• Laboratory Findings
– Mild to moderate thrombocytopenia common
– Platelets appear large on blood films
– Platelet aggregation studies
– Normal platelet aggregation in response to ADP, collagen,
and epinephrine
– Absent aggregation in response to ristocetin and vWF
Glanzmann Thrombasthenia
 Platelet aggregation
defective What is the significance
of a deficiency of this
 Inherited in autosomal receptor?
recessive pattern ** Platelets are unable to aggregate
 Consanguinity often
noted in affected families

 Missing or defective
GPIIb/IIIa complex
Glanzmann Thrombasthenia
• Clinical presentation
– Purpura and epistaxis are the most frequent
types of bleeding, especially in children
– Bleeding may decrease with age
– Great variability in bleeding even within
kindred (family)

• Laboratory findings
– Platelet count and morphology are normal
Glanzmann Thrombasthenia
Laboratory Findings:

•Normal platelet count and morphology


•Poor in vitro clot retraction
•Prolonged bleeding time
•Absent platelet aggregation to ADP, thrombin, collagen,
and epinephrine
•Normal platelet aggregation to ristocetin
•Flow cytometric assessment to GPIIb/IIIa revealing
absence or deficiency
PLATELET RELEASE OR
SECRETION DEFECTS
• Storage Pool Deficiencies (Granule Defects)
• Primary Secretion Defects
Storage Pool Disorders
• Defects in secondary aggregation
• Deficiency of contents of one of the granules
• Inheritance is variable (heterogeneous group)
• Bleeding is usually mild to moderate but can
be exacerbated by aspirin
• Clinical: easy bruising, menorrhagia, and
excessive postpartum or postoperative
bleeding
Storage Pool Disorders
• Typical Laboratory Findings:

– Usually normal platelet count


– Morphology is variable
– Platelet aggregation shows primary wave but
absence of secondary wave when stimulated
with ADP, epinephrine, arrachidonic acid
– Platelet aggregation with thrombin is usually
normal (overrides need for granule release)
– Ristocetin agglutination is normal
Storage Pool Disorders
• Delta Storage Pool Deficiency
– Decrease amount of secretable ADP, ATP, serotonin, calcium
– Often associated with disorders affecting granules in other
cells
• Chediak-Higashi Syndrome
• Hermansky-Pudlak Syndrome
• Wiskott-Aldrich Syndrome
– Platelets are small with decreased number of both
alpha and dense granules
Storage Pool Disorders
• Hermansky-Pudlak • Wiskott-Aldrich Syndrome:
Syndrome: platelet disorders of dense granules
deficiency of non-metabolic characterized by recurrent
ADP; patients with pyogenic infections,
oculocutaneous albinism Eczema, and
thrombocytopenia
• Chediak-Higashi Syndrome:
patient with ocular albinism
and characteristic silver-gray
hair with dense granule
storage pool deficiency
Storage Pool Disorders
• Alpha Storage Pool Deficiency
– Decrease amount of Platelet Factor 4, PDGF, β-
thromboglobulin
– Gray Platelet Syndrome: deficiency of the alpha granules
leading to an agranular appearance of platelets on Wright’s

• Alpha and Delta Storage Pool Deficiencies


– both
Gray Platelet Syndrome

• Alpha granule deficiency


• Clinical: mild bleeding

• Laboratory Findings:
– Thrombocytopenia: 60 - 100 x 103/L
– Platelets are large and appear “gray” on Wright’s stained
smear (hence the name)
– Marked deficiency of alpha granules
– Dense granules are normal
– Platelet aggregation studies are fairly normal since 2o
aggregation wave due primarily to dense granule release
Secretion Disorders
Inability to Release Dense Granule Contents
 No abnormalities in  Includes defects in the
platelet granules and of arachidonic acid pathway
 Deficiency of cyclo-oxygenase
normal amount thus deficient conversion of
 Release defects is arachidonic acid to tromboxane
caused by deficiencies A2
of enzymes and “second  Deficiency of thromboxane
synthetase
messengers”
 Often called “aspirin-like” defects
 Abnormalities may be in  Granules are normal by electron
the platelet stimulus- microscopy
response coupling  Bleeding with mild, just as with
 Involves the metabolic aspirin, supporting fact that there
pathways leading from are other pathways to activate
receptor occupation to platelets (e.g., thrombin) that do
platelet aggregation and not require this pathway
secretion
ABNORMAL PLATELET-COAGULANT
PROTEIN INTERACTION
• von Willebrand Disease
von Willebrand Disease
• The most common Classifications:
inherited abnormality •Type 1: quantitative decrease in
vWF and mild bleeding. Most
of platelet function common variant (80%)

•Type 2: qualitative abnormality


• Platelets that are in the structure of vWF
normal exhibit
abnormal adhesion •Type 3: absent levels of vWF
because of the absence multimers and a severe bleeding
diasthesis
or dysfunction of vWF
Acquired Qualitative Defects
 MYELOPROLIFERATIVE DISEASE
o Polycythemia vera, Chronic Myeloid Leukemia, myeloid
metaplasia
 PARAPROTEINEMIAS
o Multiple myeloma, Waldenstrom’s macroglobulinemia:
interaction of paraprotein with platelets and coagulation
factors
 UREMIA
o Uncleared metabolic product guanidinosuccinic acid acts as
inhibitor of platelet function by inducing endothelial cell Nitric
Acid release
 LIVER DISEASE
 Multifaceted defect in coagulation, high levels of circulating
fibrin degradation products, reduced production of factor VII
 DRUG THERAPY
 Aspirin: powerful inhibitor of platelet thromboxane A2
synthesis through deactivation of cyclo-oxygenase (irreversible
effect)
 NSAIDS: like ibuprofen, indomethacin. Inhibit platelet function
but is reversible

You might also like